GoHealth Historical Income Statement

GOCO Stock

USD 11.90 0.40 3.48%

Historical analysis of GoHealth income statement accounts such as Depreciation And Amortization of 100.5 M or Interest Expense of 36.9 M can show how well GoHealth performed in making a profits. Evaluating GoHealth income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of GoHealth's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining GoHealth latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GoHealth is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.

About GoHealth Income Statement Analysis

GoHealth Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to GoHealth shareholders. The income statement also shows GoHealth investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

GoHealth Income Statement Chart

At this time, GoHealth's Income Tax Expense is very stable compared to the past year. As of the 23rd of November 2024, Non Operating Income Net Other is likely to grow to about 108.7 K, while Tax Provision is likely to drop about 63.6 K.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Net Income Income Tax Expense

Total Revenue

Total revenue comprises all receipts GoHealth generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of GoHealth minus its cost of goods sold. It is profit before GoHealth operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in GoHealth financial statement analysis. It represents the amount of money remaining after all of GoHealth operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from GoHealth's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into GoHealth current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.At this time, GoHealth's Income Tax Expense is very stable compared to the past year. As of the 23rd of November 2024, Non Operating Income Net Other is likely to grow to about 108.7 K, while Tax Provision is likely to drop about 63.6 K.

	2023	2024 (projected)
Depreciation And Amortization	105.7M	100.5M
Interest Income	9.4M	9.9M

Depreciation And Amortization Interest Income

GoHealth income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Non Operating Income Net Other	Non Recurring
Tax Provision		-0.38	0.25	0.4	0.48	0.15	0.16	0.12	0.1	0.3	-0.81	-0.36	-0.4	-0.28	-0.31	0.2	0.31	0.3	-0.42	0.08	-0.44	0.98	-0.49	0.14	0.05
Net Interest Income	-0.38		-0.95	-0.47	-0.94	-0.73	-0.82	-0.81	-0.8	-0.85	0.76	0.83	0.46	0.92	0.32	-0.82	-0.86	-0.92	0.68	0.41	0.55	-0.51	0.78	0.18	0.68
Interest Income	0.25	-0.95		0.61	0.86	0.88	0.93	0.92	0.9	0.92	-0.68	-0.85	-0.58	-0.99	-0.39	0.95	0.91	0.99	-0.73	-0.56	-0.63	0.36	-0.72	-0.32	-0.54
Depreciation And Amortization	0.4	-0.47	0.61		0.59	0.57	0.77	0.8	0.8	0.84	-0.73	-0.74	-0.99	-0.66	-0.8	0.75	0.82	0.69	-0.86	-0.71	-0.9	0.38	-0.67	-0.65	0.11
Interest Expense	0.48	-0.94	0.86	0.59		0.6	0.76	0.8	0.8	0.86	-0.84	-0.83	-0.57	-0.84	-0.43	0.73	0.89	0.86	-0.73	-0.42	-0.62	0.59	-0.82	-0.23	-0.51
Selling General Administrative	0.15	-0.73	0.88	0.57	0.6		0.79	0.79	0.76	0.76	-0.45	-0.56	-0.5	-0.9	-0.16	0.89	0.72	0.88	-0.49	-0.39	-0.45	0.2	-0.38	-0.14	-0.3
Selling And Marketing Expenses	0.16	-0.82	0.93	0.77	0.76	0.79		0.97	0.96	0.96	-0.66	-0.93	-0.77	-0.94	-0.67	0.98	0.94	0.95	-0.89	-0.83	-0.83	0.23	-0.8	-0.65	-0.36
Total Revenue	0.12	-0.81	0.92	0.8	0.8	0.79	0.97		1.0	0.98	-0.65	-0.89	-0.79	-0.93	-0.62	0.95	0.97	0.93	-0.84	-0.77	-0.78	0.2	-0.76	-0.6	-0.39
Gross Profit	0.1	-0.8	0.9	0.8	0.8	0.76	0.96	1.0		0.98	-0.64	-0.88	-0.79	-0.9	-0.62	0.93	0.97	0.91	-0.84	-0.77	-0.77	0.18	-0.76	-0.61	-0.39
Other Operating Expenses	0.3	-0.85	0.92	0.84	0.86	0.76	0.96	0.98	0.98		-0.78	-0.93	-0.83	-0.93	-0.66	0.94	1.0	0.94	-0.9	-0.74	-0.84	0.37	-0.84	-0.57	-0.39
Operating Income	-0.81	0.76	-0.68	-0.73	-0.84	-0.45	-0.66	-0.65	-0.64	-0.78		0.82	0.73	0.69	0.63	-0.64	-0.79	-0.72	0.82	0.4	0.78	-0.86	0.87	0.29	0.28
Net Income From Continuing Ops	-0.36	0.83	-0.85	-0.74	-0.83	-0.56	-0.93	-0.89	-0.88	-0.93	0.82		0.78	0.85	0.78	-0.87	-0.93	-0.87	0.96	0.8	0.89	-0.44	0.97	0.66	0.43
Ebit	-0.4	0.46	-0.58	-0.99	-0.57	-0.5	-0.77	-0.79	-0.79	-0.83	0.73	0.78		0.63	0.88	-0.73	-0.82	-0.66	0.9	0.78	0.94	-0.37	0.73	0.73	-0.11
Research Development	-0.28	0.92	-0.99	-0.66	-0.84	-0.9	-0.94	-0.93	-0.9	-0.93	0.69	0.85	0.63		0.43	-0.97	-0.91	-1.0	0.75	0.59	0.68	-0.36	0.72	0.35	0.45
Ebitda	-0.31	0.32	-0.39	-0.8	-0.43	-0.16	-0.67	-0.62	-0.62	-0.66	0.63	0.78	0.88	0.43		-0.56	-0.66	-0.47	0.91	0.87	0.95	-0.29	0.8	0.9	-0.1
Cost Of Revenue	0.2	-0.82	0.95	0.75	0.73	0.89	0.98	0.95	0.93	0.94	-0.64	-0.87	-0.73	-0.97	-0.56		0.91	0.97	-0.82	-0.73	-0.77	0.26	-0.72	-0.52	-0.35
Total Operating Expenses	0.31	-0.86	0.91	0.82	0.89	0.72	0.94	0.97	0.97	1.0	-0.79	-0.93	-0.82	-0.91	-0.66	0.91		0.93	-0.89	-0.72	-0.82	0.39	-0.85	-0.55	-0.41
Reconciled Depreciation	0.3	-0.92	0.99	0.69	0.86	0.88	0.95	0.93	0.91	0.94	-0.72	-0.87	-0.66	-1.0	-0.47	0.97	0.93		-0.78	-0.61	-0.71	0.38	-0.74	-0.38	-0.42
Income Before Tax	-0.42	0.68	-0.73	-0.86	-0.73	-0.49	-0.89	-0.84	-0.84	-0.9	0.82	0.96	0.9	0.75	0.91	-0.82	-0.89	-0.78		0.85	0.98	-0.45	0.94	0.76	0.18
Total Other Income Expense Net	0.08	0.41	-0.56	-0.71	-0.42	-0.39	-0.83	-0.77	-0.77	-0.74	0.4	0.8	0.78	0.59	0.87	-0.73	-0.72	-0.61	0.85		0.85	0.07	0.71	0.96	0.07
Net Income	-0.44	0.55	-0.63	-0.9	-0.62	-0.45	-0.83	-0.78	-0.77	-0.84	0.78	0.89	0.94	0.68	0.95	-0.77	-0.82	-0.71	0.98	0.85		-0.43	0.87	0.79	0.01
Income Tax Expense	0.98	-0.51	0.36	0.38	0.59	0.2	0.23	0.2	0.18	0.37	-0.86	-0.44	-0.37	-0.36	-0.29	0.26	0.39	0.38	-0.45	0.07	-0.43		-0.57	0.16	-0.14
Minority Interest	-0.49	0.78	-0.72	-0.67	-0.82	-0.38	-0.8	-0.76	-0.76	-0.84	0.87	0.97	0.73	0.72	0.8	-0.72	-0.85	-0.74	0.94	0.71	0.87	-0.57		0.61	0.42
Non Operating Income Net Other	0.14	0.18	-0.32	-0.65	-0.23	-0.14	-0.65	-0.6	-0.61	-0.57	0.29	0.66	0.73	0.35	0.9	-0.52	-0.55	-0.38	0.76	0.96	0.79	0.16	0.61		-0.07
Non Recurring	0.05	0.68	-0.54	0.11	-0.51	-0.3	-0.36	-0.39	-0.39	-0.39	0.28	0.43	-0.11	0.45	-0.1	-0.35	-0.41	-0.42	0.18	0.07	0.01	-0.14	0.42	-0.07

Click cells to compare fundamentals

GoHealth Account Relationship Matchups

GoHealth income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	(22K)	43K	(24K)	764K	67K	63.7K
Depreciation And Amortization	33.0M	922.2M	1.2B	912.8M	105.7M	100.5M
Interest Expense	8.2M	33.0M	33.5M	57.1M	69.5M	36.9M
Selling General Administrative	182.6M	197.2M	98.2M	116.5M	93.1M	131.1M
Total Revenue	539.5M	877.4M	1.1B	631.7M	734.7M	746.5M
Gross Profit	337.0M	678.1M	823.1M	444.0M	575.7M	550.8M
Other Operating Expenses	493.1M	922.2M	1.2B	912.8M	816.4M	826.3M
Operating Income	46.4M	(44.5M)	(102.2M)	(281.1M)	(81.7M)	(85.8M)
Ebit	46.4M	(887.8M)	(1.6B)	(1.1B)	(81.6M)	(85.7M)
Ebitda	79.4M	34.4M	(393.2M)	(174.1M)	24.1M	25.3M
Cost Of Revenue	202.5M	199.2M	239.3M	187.7M	159.0M	195.7M
Total Operating Expenses	290.5M	723.0M	926.0M	725.1M	719.6M	642.1M
Income Before Tax	(41.1M)	(97.2M)	(534.2M)	(375.6M)	(151.1M)	(158.7M)
Total Other Income Expense Net	(87.5M)	(52.7M)	(432.0M)	(57.0M)	(69.4M)	(72.9M)
Net Income Applicable To Common Shares	16.0M	(18.8M)	(189.4M)	(148.7M)	(133.8M)	(127.1M)
Net Income	(41.1M)	(97.2M)	(534.2M)	(376.4M)	(63.3M)	(66.4M)
Income Tax Expense	(22K)	43K	(24K)	764K	154K	176.2K

Pair Trading with GoHealth

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GoHealth position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GoHealth will appreciate offsetting losses from the drop in the long position's value.

Moving together with GoHealth Stock

0.88	EHTH	eHealth	Pair Corr
0.83	AON	Aon PLC	Pair Corr
0.67	BRO	Brown Brown Fiscal Year End 27th of January 2025	Pair Corr

Moving against GoHealth Stock

0.78	ERIE	Erie Indemnity	Pair Corr
0.68	RELI	Reliance Global Group	Pair Corr
0.58	MMC	Marsh McLennan Companies Fiscal Year End 23rd of January 2025	Pair Corr
0.54	SLQT	Selectquote Buyout Trend	Pair Corr
0.51	ZBAO	Zhibao Technology Class	Pair Corr

The ability to find closely correlated positions to GoHealth could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GoHealth when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GoHealth - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GoHealth to buy it.

The correlation of GoHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GoHealth moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GoHealth moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for GoHealth can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether GoHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GoHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Gohealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Gohealth Stock:

How To Invest In GoHealth

Details

Is GoHealth Stock a good investment?

Details

What is GoHealth's Net Worth?

Details

Largest Property & Casualty Insurance Companies

View

Largest Insurance Brokers Companies

View

To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

4.241

Earnings Share

(3.29)

Revenue Per Share

69.776

Quarterly Revenue Growth

(0.10)

Return On Assets

(0.03)

The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GoHealth Historical Income Statement

About GoHealth Income Statement Analysis

GoHealth Income Statement Chart

Total Revenue

Gross Profit

Net Income

GoHealth income statement Correlations

GoHealth Account Relationship Matchups

High Positive Relationship

High Negative Relationship

GoHealth income statement Accounts

Pair Trading with GoHealth

Moving together with GoHealth Stock

Moving against GoHealth Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Reconciled Depreciation	+ 0.99	Interest Income
Income Tax Expense	+ 0.98	Tax Provision
Cost Of Revenue	+ 0.98	Selling And Marketing Expenses
Other Operating Expenses	+ 0.98	Total Revenue

Reconciled Depreciation	- 1.0	Research Development
Ebit	- 0.99	Depreciation And Amortization
Research Development	- 0.99	Interest Income
Cost Of Revenue	- 0.97	Research Development
Interest Income	- 0.95	Net Interest Income
Research Development	- 0.94	Selling And Marketing Expenses